Australia's Cogstate hits over 1-1/2-year high on strong full-year outlook

Cogstate

24/06/2025 03:03

** Shares of Cogstate CGS.AX rise as much as 14.8% to A$1.550, their highest level since November 24, 2023

** The biotechnology company expects FY25 revenue to be between A$52 million ($33.69 million) and A$54 million, compared with A$43.4 million last year

** Co expects FY25 profit before tax to be between A$12 million and A$14 million, compared with A$7.1 million a year ago

** Stock posts its biggest intraday pct gain since June 12

** Stock currently up 10.4%, bringing YTD gains to 29.2%

($1 = 1.5437 Australian dollars)

 (Reporting by Adwitiya Srivastava in Bengaluru)

 ((Adwitiya.Srivastava@thomsonreuters.com))